Association between tumor necrosis factor-alpha promoter polymorphism and Alzheimer's disease.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 14745077.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor necrosis factor-alpha (TNFalpha) gene polymorphisms have been reported to be associated with Alzheimer's disease (AD) in Caucasian populations. Three TNFalpha polymorphisms (-857, -863, and -1,031) were studied in a Chinese population. A high-risk TNFalpha haplotype (-1,031C-863C-857C) with an odds ratio of 2.54 (95% CI 1.37 to 4.79) for AD was identified. No interaction effect of APOE and TNFalpha genotypes was found, but both acted as important risk factors for AD.
Medical subject headings
- Alzheimer Disease
- Polymorphism, Genetic
- Tumor Necrosis Factor-alpha